Skip to main content
. 2020 Feb 10;11:816. doi: 10.1038/s41467-020-14585-6

Fig. 5. C-di-GMP-dependent ShkA activation requires PleC and PleD.

Fig. 5

a Model of ShkA-TacA phosphorelay activation and its contribution to G1/S transition. The upper part shows the intercalated network of kinases (PleC, DivJ, ShkA, CckA) and response regulators (PleD, TacA, DivK) that contribute to G1/S transition. HK indicates a hypothetical histidine kinase that controls the activity of PleD and possibly DivK (stippled lines) and by that acts as kick-starter for G1 exit. HK expression is postulated to be CtrA-mediated (stippled line). The initial, HK-PleD-mediated increase of c-di-GMP activates the ShkA-TacA pathway, resulting in a SpmX-DivJ-PleD-mediated further boost of c-di-GMP concentration, which activates the CckA phosphatase and PopA. Note that ShkA has a five- to tenfold higher affinity for c-di-GMP compared with CckA and PopA. The block of replication initiation by binding of activated CtrA to the chromosomal origin of replication (Cori) is indicated. The lower part of the graph indicates time windows of CckA kinase and phosphatase as well as TacA kinase activity. The gradual increase of c-di-GMP during G1/S is indicated. b Activity of the spmX promoter in strains harboring a spmX’-‘lacZ reporter fusion (pAK502-spmX). Shown are mean values and standard deviations (N = 3). c Activity of the tacA promoter in strains harboring a tacA’-‘lacZ fusion (pAK502-tacA). Strains with a chromosomal pleC deletion express wild type and mutant pleC alleles from plasmid pQF under control of their native promoter. PleC(F778L): Kinase−/phosphatase+ (K−P+); PleC(T614R) kinase−/phosphatase− (K−P−); - indicates the empty vector control (plasmid pQF). Shown are mean values and standard deviations (N = 3). d Immunoblots of selected strains shown in c probed with anti-SpmX and anti-MreB antibodies (top) or anti-PleC antibodies (bottom). e Immunoblots of selected strains shown in c probed with anti-SpmX and anti-MreB antibodies. f Immunoblots of indicated strains probed with anti-SpmX and anti-MreB antibodies. pPleD* indicates a pMR20-based plasmid (pPA114-47) expressing the constitutively active, phosphorylation-independent PleD* allele. EV denotes the empty plasmid control (pMR20). Source data are provided as a Source Data file.